Cholinergic function and Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 18, Issue SUPPL. 1, 2003, Pages

  Giacobini, Ezio ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alzheimer's disease; Cholinergic; Drug therapy

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; NICOTINIC AGENT; NICOTINIC RECEPTOR; RIVASTIGMINE;

ALZHEIMER DISEASE; AUTONOMIC NEUROPATHY; BEHAVIOR; BINDING SITE; BRAIN DISEASE; CHOLINERGIC SYSTEM; COGNITION; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SPECIFICITY; DRUG TARGETING; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FASCICULATION; HUMAN; MUSCLE DISEASE; MUSCLE WEAKNESS; NONHUMAN; PATHOPHYSIOLOGY; SIDE EFFECT; SYNAPSE;

AGED; ALZHEIMER DISEASE; CHOLINERGIC FIBERS; CHOLINESTERASE INHIBITORS; HUMANS; SYNAPSES;

EID: 0141818332     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.935     Document Type: Conference Paper

References (21)

1. Bartus RT, Dean RL, III, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414.
2. Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. 1986. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. Prog Brain Res 70: 105-132.
3. Court JA, Perry EK. 1991. Dementia: The neurochemical basis of putative transmitter orientated therapy. Pharmacol Ther 52: 423-443.
4. Court JA, Perry EK, Johnson M, et al. 1993. Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Brain Res Dev Brain Res 74: 73-82.
5. Davis KL, Mohs RC, Marin D, et al. 1999. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. JAMA 281: 1401-1406.
6. Geula C, Mesulam M. 1994. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In Alzheimer Disease, Terry RD, Katzman R, Bick KL (eds). Raven Press: New York: 263-291.
7. Giacobini E. 1990. The cholinergic system in Alzheimer disease. Prog Brain Res 84: 321-332.
8. Giacobini E. 1998. Cholinergic foundations of Alzheimer's disease therapy. J Physiol Paris 92: 283-287.
9. Giacobini E. 2000. Cholinesterase inhibitors: From the Calabar bean to Alzheimer therapy. In Cholinesterase and Cholinesterase Inhibitors, Giacobini E (ed.). Martin Donitz: London; 181-226.
10. Giacobini E, DeSarno P, Clark B, McIlhany M. 1989. The cholinergic receptor system of the human brain: Neurochemical and pharmacological aspects in aging and Alzheimer. Prog Brain Res 79: 335-343.
11. Giacobini E, Spiegel R, Enz A, Veroff AE, Cutler NR. 2002. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: Correlation with cognitive benefit. J Neural Transm 109: 1053-1065.
12. Herholtz K, Bauer B, Wienhard K, et al. 2000. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: Comparison with blood flow and glucose metabolism. J Neural Transm 107: 1457-1468.
13. Inglis F. 2002. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl 127: 45-63.
14. Kuhl DE, Koeppe RA, Minoshima S, et al. 1999. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52: 691-699.
15. Mesulam M. 2000. Neuroanatomy of cholinesterases in the normal human brain and in Alzheimer's disease. In Cholinesterase and Cholinesterase Inhibitors, Giacobini E (ed.). Martin Donitz: London; 121-137.
16. Mori F, Lai C-C, Fusi F, Giacobini E. 1995. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neuroreport 6: 633-636.
17. Nordberg A, Jelic V, Arnãiz E, Långström, Almqvist O. 2001. Brain functional imaging in early and preclinical Alzheimer's disease. In Alzheimer Disease: Advances in Etiology, Pathogenesis and Therapeutics, Iqbal K, Sisodia S, Winblad B (eds). John Wiley & Sons Ltd: Chichester; 153-164.
18. Perry EK. 1980. The cholinergic system in old age and Alzheimer's disease. Age Ageing 9: 1-8.
19. Rosler M. 2002. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clin Pract Suppl 127: 20-36.
20. Tiraboschi P, Hansen LA, Alford M, et al. 2000. Cholinergic function in diseases with Lewy bodies. Neurology 54: 407-411.
21. Turrini P, Casu MA, Wong TP, De Koninck Y, Ribeiro-Da-Silva A, Cuello AC. 2001. Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: Synaptic pattern and age-related atrophy. Neuroscience 105: 277-285.